Press release
United States Probiotic IBS Supplements Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities
Market Size and GrowthGlobal Probiotic IBS Supplements Market reached US$ 29.12 million in 2023 and is expected to reach US$ 48.79 million by 2031, growing with a CAGR of 7.65% during the forecast period 2024-2031.
Key Development:
United States: Recent Industry Developments
✅ In August 2025, Nestlé Health Science acquired a U.S.-based probiotic startup specializing in IBS supplements to expand its gastrointestinal health portfolio.
✅ In May 2025, Procter & Gamble partnered with a biotech firm to co-develop next-generation probiotic formulations for IBS management.
✅ In March 2025, Align Probiotics introduced an advanced IBS-focused formulation with enhanced gut microbiome support, backed by $15 million in venture funding.
Japan: Recent Industry Developments
✅ In August 2025, Morinaga Milk Industry launched a functional probiotic supplement targeting IBS relief and digestive health for Japanese consumers.
✅ In May 2025, Nomura Dairy Products launched Japan's first fermented drink fortified with Lactiplantibacillus plantarum 299v (LP299V), targeting digestive health.
✅ In April 2025, Yakult expanded its probiotic product range with an IBS-focused supplement containing clinically validated strains for gut health.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/probiotic-ibs-supplements-market?sb
Probiotic IBS supplements are dietary products containing beneficial bacteria designed to support gut health and relieve symptoms of irritable bowel syndrome (IBS). They help balance the intestinal microbiome, reduce bloating, abdominal discomfort, and irregular bowel movements, improving overall digestive well-being.
Recent Mergers and acquisitions:
United States: Recent M&A Activity
✅ In June 2025, Asahi Group Holdings acquired a domestic probiotic supplement manufacturer to strengthen its digestive health portfolio. This strategic move aims to enhance their presence in the growing IBS supplement market.
✅ In May 2025, Avista Healthcare Partners acquired Trillium Health Care Products, a contract development and manufacturing organization (CDMO) specializing in OTC and personal care products. This acquisition provides Avista with an established platform to scale in the growing self-care segment, including probiotic supplements.
✅ In April 2025, SK Capital acquired UPM Pharmaceuticals, creating a CDMO platform with capabilities in both prescription and OTC products. This acquisition highlights the strategic value of such mergers in expanding product offerings, including probiotic supplements.
Japan: Recent M&A Activity
✅ In March 2025, Yakult acquired a domestic probiotic supplement manufacturer to strengthen its digestive health portfolio. This acquisition aims to enhance their presence in the growing IBS supplement market in Japan.
✅ In February 2025, Nomura Dairy Products acquired a probiotic supplement manufacturer specializing in IBS-focused products. This strategic move aims to expand their product offerings and cater to the growing demand for digestive health solutions in Japan.
Key Players:
=> The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Pure NSM - Nutritional Supplement Manufacturers, Inc., Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd and Wren Laboratories Ltd.
Growth Forecast Projected:
The Global Probiotic IBS Supplements Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Probiotic IBS Supplements Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=probiotic-ibs-supplements-market
Key Segments:
➥ By Strain: Lactobacillus, Bifidobacterium, Other
➥ By Form: Tablet, Capsules, Liquid, Powder, Others
➥ By Distribution Channel: Supermarkets/Hypermarkets, Pharmacy/Health Stores, Online Stores, Other
➥ By End-User: Infant, Children, Adults, Seniors
Regional Analysis for Probiotic IBS Supplements Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Probiotic IBS Supplements producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Probiotic IBS Supplements revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/probiotic-ibs-supplements-market?sb
FAQ
What is the current size of the Probiotic IBS Supplements Market?
A: In 2023, the Probiotic IBS Supplements Market was valued at US$ 29.12 million, reflecting its strong industry presence.
Q2: How large is the Probiotic IBS Supplements Market expected to be by 2031?
A: By 2031, industry forecasts suggest the Probiotic IBS Supplements Market will grow to around US$ 48.79 million , demonstrating significant expansion.
Q3: What is the growth rate of the Probiotic IBS Supplements Market?
A: The market is projected to expand at a compound annual growth rate (CAGR) of 7.65% during the forecast period from 2024 to 2031.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Probiotic IBS Supplements Market 2025 | Growth Drivers, Competitive Landscape & Investment Opportunities here
News-ID: 4227668 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Global Edge AI Chip Market to Reach US$ 27.1B by 2032: AI Acceleration, IoT Inte …
Market Size and Growth
Global Edge AI chip market reached US$ 7.5 billion in 2024 and is expected to reach US$ 27.1 billion by 2032, growing with a CAGR of 17.4% during the forecast period 2025-2032.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/edge-ai-chips-market?sb
Key Development:
United States: Recent Edge AI Chip Developments
✅ In November 2025, AAEON launched a COM‐HPC Mini module powered by Intel Core…
United States Drug Delivery Devices Market Size, Share, Growth Trends, and Forec …
Leander, Texas and TOKYO, Japan - Nov. 20. 2025
The Global Drug Delivery Devices Market reached US$ 90.40 Billion in 2024 and is expected to reach US$ 151.41 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033. As per DataM Intelligence research report.
Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/drug-delivery-devices-market?praveen
United States: Recent Industry Developments
✅ March 2025 -The U.S. FDA issued updated regulatory…
United States Magnet Wire Market Size, Share, Growth Drivers, Industry Trends, O …
Market Size and Growth
The global magnet wire market is projected to grow at a CAGR of 4.1% during 2024-2031, driven by increasing demand from industries such as electronic motors, transformers, automobiles, and generators, particularly in Europe.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/magnet-wire-market?Juli
Recent Industry Developments
United States:
✅ In 2025, U.S. manufacturers reported increased demand for magnet wires in electric…
Global Spring Hinges Market to Reach US$ 12.4 B by 2031-Durable Hardware, Indust …
Market Size and Growth
Global Spring Hinges Market reached US$ 8.5 billion in 2023 and is expected to reach US$ 12.4 billion by 2031, growing with a CAGR of 4.8% during the forecast period 2024-2031.
Key Development:
✅ In November 2025, RIKEN and NVIDIA announced two new supercomputers in Japan (one dedicated to quantum computing) using NVIDIA GB200/Quantum‐X800 technology, underlining Japan's push for sovereign quantum infrastructure.
✅ In November 2025, the RIKEN Center for…
More Releases for IBS
Irritable Bowel Syndrome (IBS) Treatment Market Poised to Hit $7.68B by 2033 | S …
The Global Irritable Bowel Syndrome (IBS) Treatment Market reached US $3.61 billion in 2024 and is forecast to nearly double to US $7.68 billion by 2033, growing at a robust 8.8% CAGR from 2025 to 2033, according to DataM Intelligence's comprehensive report. IBS affects an estimated 5-10% of the global population, marking it one of the most prevalent gastrointestinal disorders with significant unmet medical needs.
👉 Download our latest market insights:…
IBS Implant Market Research Report 2023 - Valuates reports
The global IBS Implant market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Get Sample report - https://reports.valuates.com/request/sample/QYRE-Auto-35O11417/Global_IBS_Implant_Market_Research_Report_2022
North American market for IBS Implant is estimated to increase from $ million in 2023 to reach $ million by 2029, at…
Integrated Bridge Systems Market Report 2018: Segmentation by Platform (Commerci …
Global Integrated Bridge Systems market research report provides company profile for Northrop Grumman Sperry Marine (U.K.), Raytheon Anschütz (Germany), Rolls Royce (U.K.), L-3 Communications Mapps Inc. (Canada), FURUNO Electric Shokai Ltd. (Japan) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR…
IBS' solution to power China’s first Cruise Line
Trivandrum, 16 January 2013: Henna, the largest cruise ship in mainland China will run on IBS’ inventory and pricing management solution, Cruise Partner, when it makes its maiden journey on January 26, 2013. China based HNA Tourism Cruise and Yacht Management Company unveiled this cruise ship on November 28, 2012. Henna has 739 rooms for 1,965 passengers, as well as a complete range of facilities for living and entertainment. HNA…
Vikash Sureka joins IBS as Chief Financial Officer
Trivandrum (India), 17 May 2012: IBS Software Services, the leading provider of new-generation IT solutions to the global aviation industry, has appointed Mr Vikash Sureka as its Chief Financial Officer. He will head the Finance, Legal, Company Affairs and Administration functions of IBS operations world-wide.
A Chartered Accountant, Vikash has over 19 years of experience mostly in senior executive roles managing business globally with proven proficiency in Investor Relations, P&L…
Raytheon Anschütz IBS for new Intership Bulkers
Raytheon Anschütz was recently awarded a contract to supply their Integrated Bridge System (IBS) to two new bulk carriers. The bulkers will be built at New Times Shipyard in Jingjiang, China. The delivery to the Cyprus based shipping company Intership Navigation Co. Ltd., a member of the German Hartmann Group, is scheduled for August and October 2011.
The new bulkers, each with a capacity of 176,000 dwt, will be equipped…
